Concepedia

Author

M. Nooij

Leiden University Medical Center

Also Known As

M A Nooij, M Nooij, M. A. Nooij, M. Nooij, M.A Nooij, M.A. Nooij, Marianne A Nooij, Marianne A. Nooij, Marianne Nooij

52

Publications

4K

Citations

32

H-Index

36

Concepts

All Affiliations

Leiden University Medical CenterEuropean Organisation for Research and Treatment of CancerRadboud University NijmegenThe Netherlands Cancer InstituteRadboud University Medical Center
MN

About

M. Nooij is an author at Leiden University Medical Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

23

2.1K

2

Obstetrics

10

10

915

3

Health Sciences

4

4

561

4

Nursing

2

2

213

5

Orthopaedics

2

2

249

M. Nooij

×

37

Publications

3.8K

Citations

30

H-Index

YearCitations

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

Robert L. Souhami, Alan Craft, Jan W. van der Eijken,

The Lancet

1997

381

Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup

Ian Lewis, M. Nooij, Jeremy Whelan,

JNCI Journal of the National Cancer Institute

2007

344

Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group

Robert Paridaens, Luc Dirix, L.V.A.M. Beex,

Journal of Clinical Oncology

2008

319

High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer

Sjoerd Rodenhuis, M. Bontenbal, L.V.A.M. Beex,

New England Journal of Medicine

2003

259

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer

Robert Paridaens, Luc Dirix, Caroline Lohrisch,

Annals of Oncology

2003

230

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

Jeremy Whelan, Rachel C. Jinks, Anne McTiernan,

Annals of Oncology

2011

201

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

Matti Aapro, F.H. van Wijk, Giorgio Bolis,

Annals of Oncology

2003

200

“Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer

E Engelsman, J.C.M. Klijn, R.D. Rubens,

European Journal of Cancer and Clinical Oncology

1991

165

Response shift in quality of life measurement in early-stage breast cancer patients undergoing radiotherapy

S.J.T. Jansen, Anne M. Stiggelbout, M. Nooij,

Quality of Life Research

2000

109

First line hormonal treatment (HT) for metastatic breast cancer (MBC) with exemestane (E) or tamoxifen (T) in postmenopausal patients (pts) - A randomized phase III trial of the EORTC Breast Group

Robert Paridaens, P. Therasse, Luc Dirix,

Journal of Clinical Oncology

2004

108

Page 1